tiprankstipranks
Aktis Oncology, Inc. (AKTS)
NASDAQ:AKTS
US Market
AKTS
Aktis Oncology, Inc.
RESEARCH TOOLSreports

Aktis Oncology, Inc. (AKTS) Income Statement

20 Followers

Aktis Oncology, Inc. Income Statement

Last quarter (Q4 2025), Aktis Oncology, Inc.'s total revenue was $1.87M, an increase of 100.43% from previous quarter. In Q4, Aktis Oncology, Inc.'s net income was $-15.14M. See Aktis Oncology, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 6.50M$ 1.49M$ 0.00$ 0.00
Gross Profit
$ 6.50M$ 1.49M$ 0.00$ 0.00
Operating Expenses
$ 81.18M$ 53.54M$ 34.79M$ 19.76M
Depreciation and Amortization
$ 2.33M$ 1.57M$ 1.20M$ 445.00K
EBITDA
$ -72.36M$ -50.48M$ -33.60M$ -19.32M
Operating Income
$ -74.68M$ -52.05M$ -34.79M$ -19.76M
Other Income/Expenses
$ 10.95M$ 8.07M$ 6.15M$ 1.83M
Pretax Income
$ -63.73M$ -43.98M$ -28.64M$ -17.93M
Net Income
$ -63.73M$ -43.98M$ -28.64M$ -17.93M
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
 0.00 0.00 0.00 0.00
Weighted Average Shares Outstanding (Diluted)
 0.00 0.00 0.00 0.00
Currency in USD

Aktis Oncology, Inc. Earnings and Revenue History